Chiropractors in Columbiana, AL Accepting Medicare

4 Chiropractors found. Showing 1 - 4

Dr. David A Stull, DC Chiropractor Medicare: Medicare Enrolled Practice Location: 101 Highway 47 S, Suite 3, Columbiana, AL 35051 Phone: 205-225-1381

Dr. Charles Frank Chrencik, D.C Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 22767 Highway 25, Columbiana, AL 35051 Phone: 205-669-5252

Dr. Bliss Quintina Newell, D.C Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 22767 Highway 25, Columbiana, AL 35051 Phone: 205-669-5252

Hometown Chiropractic, Llc Chiropractor Medicare: Medicare Enrolled Practice Location: 204 E College St, Columbiana, AL 35051 Phone: 205-225-1381

News Archive

Researchers discover one of the mechanisms that prevents the spread of colon cancer

The first step in the development of colon cancer is the formation of benign tumours, called adenomas, in the intestine. Over time, these tumours may progress to produce colon cancer if they undergo a series of mutations and genetic alterations.

Horizon Foundation for New Jersey, YMCA Alliance announce 2.25M expansion grant for Healthy U

The Horizon Foundation for New Jersey and the New Jersey YMCA State Alliance announced today a $2.25 million expansion grant for Healthy U - a collaborative initiative to combat the obesity epidemic among New Jersey children.

Researchers simulate activity of cultured neural networks

After a short period of growth, cultured networks of neurons regularly exhibit major activity in the absence of external stimulation. These "bursts" are entirely related to growth. At this stage, they have little to do with learning behaviour, as the network is still too young to sustain a process of memory formation. This has now for the first time been simulated for networks ranging in size from 10,000 to 50,000 neurons. The simulations provide insight into the role of the growth process in initial activity.

Janssen begins rolling submission of daratumumab BLA to FDA for treatment of patients with multiple myeloma

Janssen Research & Development, LLC has initiated the rolling submission of its Biologic License Application (BLA) for daratumumab to the U.S. Food and Drug Administration (FDA) for the treatment of patients with multiple myeloma who have received at least three prior lines of therapy, including a proteasome inhibitor (PI) and an immunomodulatory agent (IMiD), or who are double refractory to a PI and an IMiD.

Read more Medical News

› Verified 9 days ago